AN2 Therapeutics, Inc. (ANTX) Net income 2021–2025
AN2 Therapeutics, Inc. (ANTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$35.2MFY2025 · since FY2021: -$21.5M → -$35.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.2M | +31.5% |
| FY2024 | -$51.3M | +20.7% |
| FY2023 | -$64.7M | -58.1% |
| FY2022 | -$41.0M | -90.1% |
| FY2021 | -$21.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice